Am sure many of you may have seen yesterday's business news on the sale of
Ovation Pharmaceuticals, Inc. to H. Lundbeck A/S (Lundbeck) of Denmark.
Ovation is the distributor in the US for Xenazine [Tetrabenazine]. This sale
is pending final approvals and antitrust clearances, and closing is expected
to take place in March 2009.

Since none of the media news articles cover the concern patients and
caregivers may have reading this news so HD families need to be assured that
Ovation is saying this sale will NOT affect the availability or support for
any of their products. They can be referred to the below Ovations press
release.

Ovation's Press Release
http://www.ovationpharma.com/press_releases_detail.php?article_id=0ef6c8f4&relea\
se_type=press&current_yr=2009

FOR PATIENTS, RELATIVES and CAREGIVERS - Today's announcement will not
affect or interfere with any product availability or support for any of the
products that Ovation currently has on the market. Likewise, there will be
no changes to the availability of support provided for Lundbeck's currently
marketed products.